About this trial
Fetal Abdominal subcutaneous tissue thickness (FASTT) can be easily measured during the routine ultrasound examination of pregnant women. Numerous reports have shown FASTT measurement to be a good way of evaluating subcutaneous fat tissue.
However, to the best of our knowledge, no studies have investigated the association of FASTT with abnormal fetal growth in nondiabetic. For this reason, in this study we evaluated whether FASTT can predict birth weight or diagnose LGA and/or LBW infants in the third trimester.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Singleton pregnancy.
Gestational age between 37-42 weeks.
Accepting to be included in the study
Disqualifiers
Pre-gestational diabetes and gestational diabetes.
Other medical disorder as hypertensive disorder during pregnancy, cardiac diseases.
Congenital fetal malformation affecting birth weight or affecting clavicle.
Trial population
pregnant women in singleton pregnancy at gestational age between 37 - 40 weeks accepting to be included in the study
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
sensitivity of measuring Fetal Abdominal Subcutaneous Tissue Thickness
To evaluate sensitivity of measuring Fetal Abdominal Subcutaneous Tissue Thickness compared to Hadlock formula IV in Prediction of Fetal Weight in Term non-diabetic Pregnant Women in 3rd trimester.
Secondary outcomes
Mode of delivery.
Vaginal delivery or cesarean section
Gestational age at the time of delivery
detection of gestational age at the time of delivery
Neonatal Apgar score
Measure Apgar score for the newborn at 1 minute and 5 minutes
Neonatal birth weight
Measure of Neonatal weight in grams
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: